88 related articles for article (PubMed ID: 38487343)
1. Genetically engineered human pituitary corticotroph tumor organoids exhibit divergent responses to glucocorticoid receptor modulators.
Mallick S; Chakrabarti J; Eschbacher J; Moraitis AG; Greenstein AE; Churko J; Pond KW; Livolsi A; Thorne CA; Little AS; Yuen KCJ; Zavros Y
Transl Res; 2023 Jun; 256():56-72. PubMed ID: 36640905
[TBL] [Abstract][Full Text] [Related]
2. A long-term prognosis study of human USP8-mutated ACTH-secreting pituitary neuroendocrine tumours.
Miao H; Wang L; Gong F; Duan L; Wang L; Yao Y; Feng M; Deng K; Wang R; Xiao Y; Ling Q; Zhu H; Lu L
Clin Endocrinol (Oxf); 2024 Jul; 101(1):32-41. PubMed ID: 38691659
[TBL] [Abstract][Full Text] [Related]
3. E-cadherin expression and gene expression profiles in corticotroph pituitary neuroendocrine tumor subtypes.
Kiseljak-Vassiliades K; Lipe K; Turin CG; Fishbein L; Costello JC; Kerr JM; Holmstoen TB; Youssef AS; Lillehei KO; Kleinschmidt-DeMasters BK; Wierman ME
J Neuropathol Exp Neurol; 2024 May; ():. PubMed ID: 38777808
[TBL] [Abstract][Full Text] [Related]
4. Somatic USP8 alteration affects the immune landscape of corticotroph pituitary adenomas- a pilot study.
Greidinger D; Halperin R; Zemet R; Maixner N; Tirosh A
Hormones (Athens); 2024 May; ():. PubMed ID: 38819743
[TBL] [Abstract][Full Text] [Related]
5. Germline Variants in Sporadic Pituitary Adenomas.
Alzahrani AS; Bin Nafisah A; Alswailem M; Alghamdi B; Alsaihati B; Aljafar H; Baz B; Alhindi H; Moria Y; Butt MI; Alkabbani AG; Alshaikh OM; Alnassar A; Bin Afeef A; AlQuraa R; Alsuhaibani R; Alhadlaq O; Abothenain F; Altwaijry YA
J Endocr Soc; 2024 Apr; 8(6):bvae085. PubMed ID: 38745824
[TBL] [Abstract][Full Text] [Related]
6. Clinical Spectrum of USP8 Pathogenic Variants in Cushing's Disease.
Rebollar-Vega RG; Zuarth-Vázquez JM; Hernández-Ramírez LC
Arch Med Res; 2023 Dec; 54(8):102899. PubMed ID: 37925320
[TBL] [Abstract][Full Text] [Related]
7. Genetics of Cushing's disease.
Simon J; Theodoropoulou M
J Neuroendocrinol; 2022 Aug; 34(8):e13148. PubMed ID: 35596671
[TBL] [Abstract][Full Text] [Related]
8. Relevance of mutations in protein deubiquitinases genes and
Pękul M; Szczepaniak M; Kober P; Rusetska N; Mossakowska BJ; Baluszek S; Kowalik A; Maksymowicz M; Zieliński G; Kunicki J; Witek P; Bujko M
Front Endocrinol (Lausanne); 2024; 15():1302667. PubMed ID: 38487343
[TBL] [Abstract][Full Text] [Related]
9. USP8, USP48, and BRAF mutations differ in their genotype-phenotype correlation in Asian Indian patients with Cushing's disease.
Abraham AP; Pai R; Beno DL; Chacko G; Asha HS; Rajaratnam S; Kapoor N; Thomas N; Chacko AG
Endocrine; 2022 Feb; 75(2):549-559. PubMed ID: 34664215
[TBL] [Abstract][Full Text] [Related]
10. Clinical, Biological, Radiological Pathological and Immediate Post-Operative Remission of Sparsely and Densely Granulated Corticotroph Pituitary Tumors: A Retrospective Study of a Cohort of 277 Patients With Cushing's Disease.
Rak B; Maksymowicz M; Pękul M; Zieliński G
Front Endocrinol (Lausanne); 2021; 12():672178. PubMed ID: 34135861
[TBL] [Abstract][Full Text] [Related]
11. USP8 and TP53 Drivers are Associated with CNV in a Corticotroph Adenoma Cohort Enriched for Aggressive Tumors.
Uzilov AV; Taik P; Cheesman KC; Javanmard P; Ying K; Roehnelt A; Wang H; Fink MY; Lau CY; Moe AS; Villar J; Bederson JB; Stewart AF; Donovan MJ; Mahajan M; Sebra R; Post KD; Chen R; Geer EB
J Clin Endocrinol Metab; 2021 Mar; 106(3):826-842. PubMed ID: 33221858
[TBL] [Abstract][Full Text] [Related]
12. TP53 mutations in functional corticotroph tumors are linked to invasion and worse clinical outcome.
Perez-Rivas LG; Simon J; Albani A; Tang S; Roeber S; Assié G; Deutschbein T; Fassnacht M; Gadelha MR; Hermus AR; Stalla GK; Tichomirowa MA; Rotermund R; Flitsch J; Buchfelder M; Nasi-Kordhishti I; Honegger J; Thorsteinsdottir J; Saeger W; Herms J; Reincke M; Theodoropoulou M
Acta Neuropathol Commun; 2022 Sep; 10(1):139. PubMed ID: 36123588
[TBL] [Abstract][Full Text] [Related]
13. The expression of glucocorticoid and mineralocorticoid receptors in pituitary tumors causing Cushing's disease and silent corticotroph tumors.
Kober P; Rusetska N; Mossakowska BJ; Maksymowicz M; Pękul M; Zieliński G; Styk A; Kunicki J; Działach Ł; Witek P; Bujko M
Front Endocrinol (Lausanne); 2023; 14():1124646. PubMed ID: 37065760
[TBL] [Abstract][Full Text] [Related]
14. Insights into Regulators of p53 Acetylation.
Nagasaka M; Miyajima C; Aoki H; Aoyama M; Morishita D; Inoue Y; Hayashi H
Cells; 2022 Nov; 11(23):. PubMed ID: 36497084
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
